Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. (Q55050612)

16 June 2018

editorial

0 references

title

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. (English)

1 reference

16 June 2018

0 references

4

1 reference

16 June 2018

Gema Ariceta

1

object named as

Gema Ariceta

1 reference

16 June 2018

Sally Johnson

3

object named as

Sally Johnson

1 reference

16 June 2018

Christoph Licht

6

object named as

Christoph Licht

1 reference

16 June 2018

author name string

Nesrin Besbas

2

1 reference

16 June 2018

Daniel Landau

5

1 reference

16 June 2018

Chantal Loirat

7

1 reference

16 June 2018

Carmine Pecoraro

8

1 reference

16 June 2018

C Mark Taylor

9

1 reference

16 June 2018

Nicole Van de Kar

10

1 reference

16 June 2018

Johan Vandewalle

11

1 reference

16 June 2018

Lothar B Zimmerhackl

12

1 reference

16 June 2018

European Paediatric Study Group for HUS

13

1 reference

16 June 2018

publication date

18 September 2008

1 reference

16 June 2018

published in

Pediatric Nephrology

1 reference

16 June 2018

volume

24

1 reference

16 June 2018

page(s)

687-696

1 reference

16 June 2018

issue

4

1 reference

16 June 2018

https://scigraph.springernature.com/pub.10.1007/s00467-008-0964-1

exact match

0 references

cites work

A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-008-0964-1

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome

21 January 2018

1 reference

12 December 2020

Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study

1 reference

12 December 2020

Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection

1 reference

12 December 2020

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Con

1 reference

12 December 2020

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias

1 reference

12 December 2020

Familial hemolytic uremic syndrome associated with complement factor H deficiency

1 reference

12 December 2020

The management of thrombotic thrombocytopenic purpura in 2005.

1 reference

12 December 2020

Complement factor H-associated atypical hemolytic uremic syndrome in monozygotic twins: concordant presentation, discordant response to treatment

1 reference

12 December 2020

Successful prophylactic plasma infusions in recurrent atypical hemolytic-uremic syndrome

1 reference

12 December 2020

Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.

1 reference

12 December 2020

Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood

1 reference

12 December 2020

Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality

1 reference

12 December 2020

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

1 reference

12 December 2020

Thrombotic microangiopathies associated with drugs and bone marrow transplantation

1 reference

12 December 2020

Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem?

1 reference

12 December 2020

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient

1 reference

12 December 2020

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

1 reference

12 December 2020

Where next with atypical hemolytic uremic syndrome?

1 reference

12 December 2020

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Successful plasma therapy in hemolytic uremic syndrome with factor H deficiency.

1 reference

12 December 2020

Complications of apheresis in children.

1 reference

12 December 2020

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

1 reference

12 December 2020

Successful treatment of factor H-related haemolytic uraemic syndrome

1 reference

12 December 2020

Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France

1 reference

12 December 2020

Challenges in the management of infantile factor H associated hemolytic uremic syndrome.

1 reference

12 December 2020

Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate

1 reference

12 December 2020

Secondary failure of plasma therapy in factor H deficiency

1 reference

12 December 2020

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

1 reference

12 December 2020

An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations

1 reference

12 December 2020

Blood pressure centiles for Great Britain.

1 reference

12 December 2020

Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects

1 reference

12 December 2020

10.1007/S00467-008-0964-1

Identifiers

DOI

1 reference

16 June 2018

Dimensions Publication ID

0 references

1 reference

16 June 2018